Litespeed Management Maintains Position in Rite Aid Ord (RAD); Perceptive Advisors Cut Its …

//Litespeed Management Maintains Position in Rite Aid Ord (RAD); Perceptive Advisors Cut Its …

Litespeed Management Maintains Position in Rite Aid Ord (RAD); Perceptive Advisors Cut Its …

September 17, 2017 – By Max Morgan

Joseph Edelman decreased its stake in Ophthotech Corp Put 20 01/20/2017 (Put) (OPHT) by 99.27% based on its latest 2016Q4 regulatory filing with the SEC. Perceptive Advisors Llc sold 218,800 shares as the company’s stock declined 45.33% while stock markets rallied. The hedge fund run by Joseph Edelman held 1,600 shares of the major pharmaceuticals company at the end of 2016Q4, valued at $24,000, down from 220,400 at the end of the previous reported quarter. Perceptive Advisors Llc who had been investing in Ophthotech Corp Put 20 01/20/2017 (Put) for a number of months, seems to be less bullish one the $90.58 million market cap company. The stock increased 1.20% or $0.03 on September 15, reaching $2.52. About 524,062 shares traded or 1.54% up from the average. Ophthotech Corp (NASDAQ:OPHT) has declined 94.82% since September 17, 2016 and is downtrending. It has underperformed by 111.52% the S&P500.

Jamie Zimmerman increased its stake in Rite Aid Ord (RAD) by 3.6% based on its latest 2016Q4 regulatory filing with the SEC. Litespeed Management Llc bought 165,000 shares as the company’s stock declined 41.75% while stock markets rallied. The hedge fund run by Jamie Zimmerman held 4.75M shares of the medical and nursing services company at the end of 2016Q4, valued at $39.15M, up from 4.59M at the end of the previous reported quarter. Litespeed Management Llc who had been investing in Rite Aid Ord for a number of months, seems to be bullish on the $2.77B market cap company. The stock increased 5.20% or $0.13 on September 15, reaching $2.63. About 59.84M shares traded or 233.93% up from the average. Rite Aid Corporation (NYSE:RAD) has declined 55.18% since September 17, 2016 and is downtrending. It has underperformed by 71.88% the S&P500.

Since April 1, 2017, it had 0 insider purchases, and 2 sales for $28,065 activity. The insider Redlick David E sold $1,764.

Investors sentiment decreased to 0.69 in 2016 Q4. Its down 0.46, from 1.15 in 2016Q3. It dived, as 84 investors sold OPHT shares while 28 reduced holdings. 33 funds opened positions while 44 raised stakes. 20.03 million shares or 40.43% less from 33.63 million shares in 2016Q3 were reported. Everpoint Asset Mngmt Limited Com accumulated 0.02% or 250,000 shares. Jacobs Levy Equity invested in 26,310 shares or 0% of the stock. Creative Planning reported 0% stake. California State Teachers Retirement invested 0% in Ophthotech Corp (NASDAQ:OPHT). Tiaa Cref Inv Management Limited Liability Corp owns 139,742 shares for 0% of their portfolio. Citadel Ltd Company accumulated 81,266 shares. Deutsche Savings Bank Ag reported 20,755 shares stake. Canada Pension Plan Investment Board holds 0% of its portfolio in Ophthotech Corp (NASDAQ:OPHT) for 26,500 shares. Walleye Trading Limited Liability Com has 133,971 shares. Schwab Charles Invest Management reported 68,238 shares stake. Susquehanna Grp Inc Llp stated it has 0% in Ophthotech Corp (NASDAQ:OPHT). Alliancebernstein Limited Partnership owns 0% invested in Ophthotech Corp (NASDAQ:OPHT) for 43,140 shares. Tudor Invest Et Al stated it has 0.01% of its portfolio in Ophthotech Corp (NASDAQ:OPHT). Pictet Asset Mngmt has 53,042 shares for 0% of their portfolio. 213 are owned by Mufg Americas.

Analysts await Ophthotech Corp (NASDAQ:OPHT) to report earnings on November, 14. They expect $4.31 earnings per share, up 352.05% or $6.02 from last year’s $-1.71 per share. OPHT’s profit will be $154.92M for 0.15 P/E if the $4.31 EPS becomes a reality. After $-0.62 actual earnings per share reported by Ophthotech Corp for the previous quarter, Wall Street now forecasts -795.16% EPS growth.

More notable recent Ophthotech Corp (NASDAQ:OPHT) news were published by: Fool.com which released: “Cohen’s Point72 Bets Big Ahead of Ophthotech Corp. Trial Results” on December 09, 2016, also Seekingalpha.com with their article: “Roche lampalizumab flop weighs on Ophthotech, down 10%” published on September 08, 2017, Fool.com published: “Here’s Why Ophthotech Corporation Is Being Obliterated Today” on December 12, 2016. More interesting news about Ophthotech Corp (NASDAQ:OPHT) were released by: Streetinsider.com and their article: “Ophthotech Corp (OPHT) Phase 3 Trial of Fovista in Wet AMD Didn’t Meet Primary …” published on August 14, 2017 as well as Seekingalpha.com‘s news article titled: “Ophthotech: 3 Strikes And It’s Out?” with publication date: August 21, 2017.

Among 12 analysts covering Ophthotech Corporation (NASDAQ:OPHT), 3 have Buy rating, 0 Sell and 9 Hold. Therefore 25% are positive. Ophthotech Corporation had 24 analyst reports since August 4, 2015 according to SRatingsIntel. Gabelli downgraded the shares of OPHT in report on Tuesday, December 13 to “Hold” rating. Citigroup maintained it with “Buy” rating and $92 target in Thursday, August 4 report. Oppenheimer reinitiated it with “Outperform” rating and $95.0 target in Friday, August 14 report. On Monday, December 12 the stock rating was downgraded by JP Morgan to “Neutral”. The stock of Ophthotech Corp (NASDAQ:OPHT) earned “Neutral” rating by Citigroup on Monday, December 12. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, August 6. The stock has “Overweight” rating by Barclays Capital on Wednesday, April 27. JP Morgan upgraded Ophthotech Corp (NASDAQ:OPHT) rating on Thursday, June 2. JP Morgan has “Overweight” rating and $84 target. As per Monday, December 12, the company rating was downgraded by Chardan Capital Markets. Barclays Capital downgraded the stock to “Equal-Weight” rating in Monday, December 12 report.

More notable recent Rite Aid Corporation (NYSE:RAD) news were published by: Businesswire.com which released: “Rite Aid Corporation Announces Leadership Changes” on September 06, 2017, also Investorplace.com with their article: “Rite Aid Corporation (RAD) Stock Can’t Beat This Retail Alternative” published on September 08, 2017, Seekingalpha.com published: “Is It The Right Time For Rite Aid?” on September 01, 2017. More interesting news about Rite Aid Corporation (NYSE:RAD) were released by: Investorplace.com and their article: “Can Rite Aid Corporation (RAD) Stock Survive on its Own?” published on August 31, 2017 as well as Investorplace.com‘s news article titled: “Get Ready for the Rally in Rite Aid Corporation (RAD) Stock” with publication date: August 29, 2017.

Litespeed Management Llc, which manages about $2.36B and $217.25M US Long portfolio, decreased its stake in Rad Apr7 8.0 C (Call) (NYSE:RAD) by 4.59 million shares to 95 shares, valued at $8,000 in 2016Q4, according to the filing.

Investors sentiment decreased to 0.92 in 2016 Q4. Its down 0.26, from 1.18 in 2016Q3. It fall, as 67 investors sold RAD shares while 114 reduced holdings. 39 funds opened positions while 128 raised stakes. 598.79 million shares or 0.81% more from 593.98 million shares in 2016Q3 were reported. Longfellow Invest Mgmt Limited Liability Company accumulated 900,000 shares or 2.93% of the stock. Fny Managed Accounts Limited Co holds 0% or 3,250 shares. Hudson Bay Mngmt Ltd Partnership reported 400,000 shares. Legal & General Grp Pcl holds 1.32 million shares or 0.01% of its portfolio. Nadler Fincl Gp invested in 10,000 shares. Northwestern Mutual Wealth has 4,144 shares for 0% of their portfolio. Two Sigma Secs Lc reported 0.16% in Rite Aid Corporation (NYSE:RAD). Lpl Llc has invested 0% in Rite Aid Corporation (NYSE:RAD). Ancora Ltd invested 0.02% in Rite Aid Corporation (NYSE:RAD). Putnam Fl Inv Mgmt Communications holds 92,455 shares. Omni Partners Limited Liability Partnership holds 2.2% or 1.19 million shares in its portfolio. Next Financial reported 36,900 shares. Meiji Yasuda Asset Mgmt Limited, Japan-based fund reported 13,650 shares. Tyrus Capital Sam owns 824,405 shares or 1.7% of their US portfolio. Nordea Invest Mngmt invested 0% of its portfolio in Rite Aid Corporation (NYSE:RAD).

Among 12 analysts covering Rite Aid (NYSE:RAD), 2 have Buy rating, 2 Sell and 8 Hold. Therefore 17% are positive. Rite Aid had 18 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Rite Aid Corporation (NYSE:RAD) has “Hold” rating given on Monday, September 11 by Loop Capital Markets. As per Thursday, September 17, the company rating was maintained by Mizuho. Bank of America initiated Rite Aid Corporation (NYSE:RAD) on Thursday, August 13 with “Buy” rating. The stock of Rite Aid Corporation (NYSE:RAD) earned “Neutral” rating by JP Morgan on Friday, November 13. The stock of Rite Aid Corporation (NYSE:RAD) has “Neutral” rating given on Thursday, October 29 by Credit Suisse. The stock of Rite Aid Corporation (NYSE:RAD) has “Buy” rating given on Wednesday, August 19 by Vetr. The firm earned “Hold” rating on Wednesday, January 6 by Evercore. As per Friday, April 8, the company rating was downgraded by Deutsche Bank. Evercore reinitiated the shares of RAD in report on Friday, June 30 with “Underperform” rating. Bank of America reinitiated the shares of RAD in report on Friday, June 30 with “Underperform” rating.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

2017-09-17T14:15:00+00:00
post